What is Zarah?
Zarah, a generic version of Yasmin, is from Watson Pharmaceuticals, which is now known as Actavis, Inc. (as of January 2013).
Zarah birth control pills contain ethinyl estradiol and the new "fourth generation" progestin drospirenone (DRSP).
The only other birth control pills, or oral contraceptives, which contain ethinyl estradiol and drospirenone are:
YAZ and Yasmin from Bayer HealthCare Pharmaceuticals, Inc.;
Ocella and Gianvi from Teva Pharmaceuticals and Barr Laboratories; and,
Loryna and Syeda from Sandoz, Inc.
In addition, there are Beyaz, which contains the same estrogen-progestin combination as YAZ plus 0.451 mg of levomefolate calcium, and Safyral, which contains the same estrogen-progestin combination as Yasmin plus 0.451 mg of levomefolate calcium.
These five birth control pills with DRSP have been associated with various adverse side effects, such as:
- Blood Clots
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Cerebrovascular Accidents (CVA)
- Heart Attack
- Myocardial Infarction
- Free YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral Case Evaluation
- The information you provide to us for this Free Case Evaluation will be treated as strictly confidential. You will get a reply from us no later than the next business day. Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit. We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.
YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral: Serious Side-Effects Lawsuit News And Information Hub
This is an up-to-date collection of drug injury lawyer blog posts and selected news articles regarding legal claims involving YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral birth control pills.
Ocella, Yasmin, YAZ, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Can Cause Pulmonary Embolism, Deep Vein Thrombosis, Stroke, And Heart Attack
Some medical journal articles are linking certain oral contraceptives, such as Ocella, Yasmin, Zarah, Syeda, YAZ, Gianvi, Loryna, Beyaz, and Safyral to pulmonary embolism (PE) and deep vein thrombosis (DVT). These birth control pills each contain drospirenone (DRSP), a unique progestin which causes an increased risk of thromboembolism, or blood clot, side effects when compared to older oral contraceptives (OCs). Estrogen and DRSP create a potentially life-threatening combination due to their coagulative effects.
How And Why YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Pills Might Cause A Higher Rate Of Blood Clots In Women
All hormonal birth control options are associated with some health risks. However, the oral contraceptive pills YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral have the distinction of being associated with a possible higher rate of blood clots which can cause serious side effects – namely, stroke, heart attack, pulmonary embolism, and deep vein thrombosis. The obvious questions are “How?” and “Why?”.
Are The Current Warnings About Blood Clot Side Effects Associated With YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Beyaz, And Safyral Sufficient?
Although the package inserts for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral carry a bolded warning for the increased risk of hyperkalemia associated with these birth control pills, any warnings for the associated blood clot risks are found in only regular print. Now lawsuits are being filed on behalf of women who used these birth control pills alleging there has been a failure to warn about the increased risk of blood clots.
Blood Clot Side Effects Have Long Been A Safety Issue For Yasmin As Well As Its Generic Versions, Ocella, Zarah, And Syeda
Soon after the Yasmin birth control pill was approved in 2000 there were reports of pulmonary embolism (PE) and deep vein thrombosis (DVT). As a result in 2002 general practitioners in The Netherlands were warned against prescribing Yasmin over the well-known second generation birth control pills.
Oral Contraceptives Such As YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Found To Increase The Risk For Gallbladder Disease
- Increasingly, medical studies are finding a clear and formidable link between hormonal contraceptive pills like YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral and gallbladder complications. These gallbladder injuries, such as acute cholecystitis, often end in gallbladder removal surgery, or cholecystectomy.
Pulmonary Embolism And Deep Vein Thrombosis: Symptoms, Treatment, and Recovery
For women who are using estrogen-progestin methods of birth control -- such as YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral -- here is some important information about symptoms, treatment and recovery from a blood clot, which is a serious, potentially fatal side effect of these birth control products.
YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Class Actions
We believe that people who suffered a serious injury or death due to the YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral oral contraceptive pills are better served when an individual lawsuit is filed on their behalf. A serious injury or death case should not be filed as part of any YAZ, Yasmin, Ocella, Gianvi, Loryna, Syeda, Zarah, Beyaz, or Safyral class action together with the claims of many other people who may have had different injuries caused by these birth control pills.
Legal Compensation for YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, And Safyral Injuries
If you experienced serious side effects from the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral, or a person died due to an adverse reaction while taking these birth control pills containing drospirenone (DRSP), you may have a claim for legal compensation. Legal compensation claims involving injuries or death caused by the use of YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, or Safyral are made by filing a lawsuit in court. All states have statutes of limitations that determine the deadlines by which to file lawsuits involving these drospirenone (DRSP) oral contraceptives.
YAZ / Yasmin / Ocella / Gianvi / Zarah / Loryna / Syeda / Beyaz / Safyral Information
YAZ, Yasmin, Ocella, Gianvi, Zarah, Loryna, Syeda, Beyaz, and Safyral are popular birth control pills made with ethinyl estradiol (EE) and the new "fourth generation" progestin, or progesterone, drospirenone (DRSP). These four DRSP oral contraceptives have been associated with potentially fatal blood-clot side effects such as deep vein thrombosis (DVT), pulmonary embolism (PE), strokes, and heart attacks. Other associated serious side effects are gallbladder problems (cholecystitis) and gallbladder removal (cholecystectomy).
Drug Injury Watch: Zarah News And Commentary
As Bayer Settlements For YAZ, Yasmin, Ocella, And Gianvi Continue In 2013, Total Payments Will Go Over The $1 Billion Level
According To Bayer 2012 Annual Report, More Than 3200 Blood Clot Claims Remain Unsettled And Additional Lawsuits Are Anticipated By Drug Company
SUMMARY: Bayer has thus far acknowledged the existence of about 8000 claims for blood clot-related side effects -- e.g., deep vein thrombosis (DVT) and/or pulmonary embolism (PE) -- arising from the use of these drospirenone (DRSP) birth control pills: YAZ, Yasmin, Ocella, Gianvi, Beyaz, and Safyral.
As of February 12, 2013 Bayer had settlement agreements for approximately 4,800 of those lawsuits, with a total payment amount of about $1 billion.
[Read this article in full at original source]
Earlier Zarah related articles by Tom Lamb on the Drug Injury Watch blog:
Some Newer Contraceptive Methods Such As NuvaRing And YAZ / Yasmin Are Under Increasing Scrutiny Over In Europe
November 2012 Litigation And Settlement Update: YAZ, Yasmin, Ocella, And Gianvi Lawsuits
2012 FDA Report On Beyaz Points Out That Younger Women and Girls Are Most At-Risk For Blood Clots
Bayer Settlements: Gianvi / Ocella / Yasmin / YAZ: July 2012 Update On Drug Injury Lawsuits Filed To Date
Medical Study Finds Link Between YAZ / Yasmin And Irritable Bowel Syndrome (IBS) Coming From Drospirenone (DRSP) Progestin
Bayer Settlements For YAZ / Yasmin Lawsuits Involving Blood Clot Side Effects Like Deep Vein Thrombosis And Pulmonary Embolism
April 2012 Yasmin / YAZ Label Change: FDA Warns About Increased Risk Of Blood Clots Possible Due To Drospirenone
Yasmin Litigation Update: 11,300 Lawsuits Have Been Served Upon Bayer As Of February 1, 2012
Yasmin / Safyral / Beyaz: February 2012 Label Change Non-Specific To These Bayer Birth Control Pills
Gianvi Legal Claims Against Drug Company Still Possible Despite Mensing Case Rule Against Generic Drug Injury Lawsuits
YAZ / Yasmin January 2012 Update: Minutes And Transcripts For FDA Advisory Committees 2011 Meeting Now Available Online (And More)
YAZ / Yasmin: December 2011 FDA Advisory Committees Meeting Background Materials Now Available Online
Another Generic YAZ Birth Control Pill Is Approved, Just One Week Before FDA Drug Safety Meeting
Two More Medical Studies Show Increased Risk Of Blood Clots With Use Of YAZ, Yasmin, And Ocella
YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot
Side Effects Like DVT, PE, Stroke, And Heart Attack
All content by attorney Tom Lamb